Contact
Please use this form to send email to PR contact of this press release:
NKGen Biotech Receives IND Clearance from FDA for SNK02 Allogeneic Natural Killer Cell Therapy for Solid Tumors
TO:
Please use this form to send email to PR contact of this press release:
NKGen Biotech Receives IND Clearance from FDA for SNK02 Allogeneic Natural Killer Cell Therapy for Solid Tumors
TO: